TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SERA

Sera Prognostics Inc

Healthcare · Medical Devices

2.10$ +2.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Sera Prognostics Inc (SERA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 87 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SERA
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 15 63 95 154 147 135 125 117 116 106 97 90 95 90 85 79 73 118 112 108 102 94 87
21 – – 14 60 91 122 110 109 108 91 90 72 64 48 61 54 52 51 48 47 41 44 41 50 48
-21 – – 14 60 91 82 59 64 54 39 30 27 32 9.7 3.9 4.2 4.7 2.7 4.0 5.2 5.0 4.1 3.9 4.2 4.4
21 – – 14 60 91 120 105 108 107 89 83 71 64 46 49 53 51 50 46 46 40 43 39 47 46
– – – 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.1 6.1 0.1 0.2 0.2 11 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
– – – – – 0.0 – – – – 0.0 0.0 0.0 0.0 0.0 – 0.0 0.0 – – – – – – – –
– – – – 0.8 0.9 1.2 1.8 2.9 3.0 3.1 – – 3.9 – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – 0.7 1.0 1.0 1.0 1.0 0.9 0.9 0.9 0.9
– – – 12 4.3 3.4 3.7 8.5 7.7 8.2 9.4 17 15 16 15 25 25 25 24 25 23 24 26 27 26 27
– – – 11 3.7 3.2 3.5 8.4 6.9 7.3 8.7 16 14 14 14 24 25 25 24 25 23 24 24 24 23 24
– – – 8.1 0.8 0.1 0.1 0.1 0.8 0.8 0.6 1.0 1.0 1.0 1.0 1.0 1.0 1.0 0.9 0.8 0.6 0.4 0.0 0.0 – –
– – – 0.4 0.8 1.0 1.3 1.2 0.9 0.8 1.1 1.5 1.6 1.2 1.2 1.0 1.0 1.0 1.4 2.0 1.2 1.1 1.0 0.9 0.8 1.2
– – – 0.3 0.3 – – – – – – – – – – – – – – – – – – – – –
11 – – 2.9 58 92 150 139 127 117 107 99 90 81 75 70 65 60 55 48 95 88 82 75 68 59
– – – -131 -138 -144 -154 -166 -179 -190 -201 -211 -221 -232 -239 -247 -255 -263 -271 -280 -288 -296 -304 -312 -320 -329
18 18 18 18 31 31 25 31 31 31 31 31 31 31 31 31 32 33 34 34 42 49 50 50 50 50

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?